Annex 2 - Documents accompanying the Minister's
letter
Annex A - Legal basis of the appointment
The Biotechnology and Biological Sciences Research
Council (BBSRC) was established by Royal Charter in 1993. Appointments
are made by the Secretary of State for Business Innovation and
Skills under the terms of section 4 of its Royal Charter.
(1) The Council shall consist of a Chairman, a Chief
Executive and Deputy Chairman, and not less than ten nor more
than eighteen other members, at least half of whom shall be appointed
by reason of their qualifications in science or engineering.
(2) Subject to the provisions of paragraph (3) of
this Article, the Chairman, the Chief Executive and Deputy Chairman,
and the other members shall be appointed and the terms of their
appointment or the revocation of any appointment determined by
Our Chancellor.
(3) (a) Before appointing any member, including
the Chairman and the Chief Executive and Deputy Chairman, on account
of his qualifications in science or engineering, Our Chancellor
shall consult the President for the time being of Our Royal Society
or of Our Royal Academy of Engineering as Our Secretary of State
shall see fit.
(b) Before appointing any member, including the Chairman
and the Chief Executive and Deputy Chairman, Our Chancellor shall
consult the Chair for the time being of the Council, who may consult
other members of the Council as he shall see fit.
(4) Every member, including the Chairman and the
Chief Executive and Deputy Chairman, shall hold and vacate his
office solely in accordance with the terms of his appointment,
and shall, on the expiry of his term of appointment, be eligible
for re-appointment but
(a) a member shall not be appointed for a term of
more than four years;
(b) a member who is re-appointed on ceasing to be
a member shall not again be eligible for re-appointment before
the expiration of one year from the end of the period for which
he is re-appointed: provided that this sub-paragraph shall not
apply to a person appointed to serve as Chair or Chief Executive
and Deputy Chairman; and
(c) a member may at any time by notice in writing
to Our Chancellor to resign his office.
(5) Except as provided in paragraph (7) of this Article,
the Council shall in the case of any such member as Our Chancellor
may determine
(a) pay to him such remuneration and allowances as
may be so determined in his case; and
(b) pay to or in respect of him such pension, allowance
or gratuity on his retirement or death, or make such payments
towards provision for such a pension, allowance or gratuity, as
may be so determined in his case.
(6) If a person ceases to be a
member of the Council otherwise than on the expiration of his
term of office, and it appears to Our Chancellor that there are
special circumstances which make it right that that person should
receive compensation, the Council shall make to that person a
payment of such amount as Our Chancellor may determine.
(7) The Council shall not in any
circumstances or at any time make to or in respect of any person
in his capacity as a member of the Council any payment of any
kind whatsoever for or in respect of any period when he is also
a member of Our Commons House of Parliament, other than a payment
by way of reimbursement to him of actual out of pocket expenses
previously and necessarily incurred by him in the performance
of his duties as such member of the Council.
(8) The provisions of paragraphs
(5) and (6) of this Article shall not apply to a member who is
an officer of a Department of Our Government.
THE RECRUITMENT PROCESS
The process followed the recommendations of the Code
of Practice of the Commissioner for Public Appointments as it
applies to upper tier bodies. It was overseen by a panel:
Sara Nathan, OCPA Public Appointments Assessor (PAA)
and Chair
Sir John O'Reilly, then Director General Knowledge
and Innovation at BIS
Jeremy Clayton Director Research Base at BIS
Jenny Dibden Director Research Base at BIS
Judith Batchelar (independent)
After preparation of information packs, which include
details of the role and person specifications and terms and conditions
and which were approved by the OCPA public appointments assessor,
the post was advertised. Advertising took place on the websites
of BBSRC, RCUK and Cabinet Office. Saxton Bampfylde conducted
the executive search and the job was also advertised on their
website. The closing date was originally 04 July but this was
extended to 16 July. Following consideration of the applications
the panel held long listing and short listing meetings on 14 July
and 16 September respectively. Ten candidates were selected after
longlisting, and after shortlisting five candidates were selected
for interview, one of whom withdrew before interview. Interviews
were held on 24 October. In accordance with the Royal Charter
the current Chair Sir Tom Blundell and the President of the Royal
Society Sir Paul Nurse were consulted. Recommendations were then
made by the Minister for Universities, Science and Cities who
considered their advice and met with the two appointable candidates.
Professor Sir Gordon Duff was offered the role. The Minister has
consulted the Prime Minister who has indicated that he is content.
Annex B - Job description and person specification
THE COUNCIL
The Biotechnology and Biological Sciences Research
Council (BBSRC) is a public body with a Royal Charter operating
as an executive non-departmental public body accountable through
the Director General Knowledge and Innovation (DGK&I) to the
Secretary of State for Business Innovation and Skills and the
Minister of State for Universities and Science.
The BBSRC's primary purposes as set out in its Royal
Charter are:
· to promote
and support, by any means, high quality research relating to the
understanding and exploitation of biological systems;
· to provide
trained scientists and engineers and to advance knowledge and
technology thereby contributing to UK economic competitiveness
and the quality of life;
· to promote
public engagement with its research.
For 2013-14 BBSRC's budget is in the region of £500
million per annum of which some £112 million is for capital
and it is the direct employer of some 1,580 people (while its
direct funding creates employment in HEIs for many more). A recent
change to the governance of funded institutes means that BBSRC's
direct employee base will fall over time, as new recruits at independent
strategic partner research institutes[3]
are employed by the institutes directly.
Since 2010, BBSRC has benefited from additional capital
allocations totalling over £225 million. It provides strategic
funding to eight institutes (including two embedded in HEIs, the
IBERS (Institute of Biological Environmental and Rural Sciences)
at Aberystwyth and the Roslin Institute at Edinburgh. It has also
played a key role in the development of campuses at these institutes
in order to further the translation of the excellent bioscience
research it funds into benefits for society and the economy.
BBSRC also works closely with other Research Councils
through Research Councils UK (RCUK) to:
· create
a common framework for research, training, knowledge transfer;
and
· harmonise,
wherever possible, services to the academic and stakeholder communities
and other science funders (both UK and international).
As well as its campus strategy, BBSRC is strongly
focused on other means of enabling and supporting impact from
the outputs and outcomes of the research in which it invests.
This is achieved by working with research-intensive and other
bioscience-using businesses in the major industrial sectors that
are supported by BBSRC-science. These include agriculture and
food, biopharmaceuticals, biorenewables and bioenergy and the
wider industrial biotechnology sector.
Its work particularly complements the work of the
Medical Research Council (MRC) in funding the UK's life sciences
and the Natural Environment Research Council (NERC), for example
on sustainable agriculture. BBSRC collaborates closely with Government
through DEFRA, DFID, the Technology Strategy Board (TSB) and the
Higher Education Funding Councils and with industry through a
variety of approaches, including collaborative groups with companies
designed to promote the translation and take-up of the outcomes
of BBSRC-supported research.
A recent survey of key stakeholders shows that BBSRC
is a highly regarded organisation which already plays an important
part in shaping the research landscape in the UK. The new Chair
will join at an important time as BBSRC develops a new strategic
plan and prepares for the next spending review.
THE ROLE
The post of Chair of BBSRC becomes vacant on 1 July
2015 when the present Chair's term ends.
In this highly influential role, the Chair will work
with the Chief Executive who is also the Council's Accounting
Officer, and the Council, leading the BBSRC in pursuit of its
objectives. The Chair acts as custodian for the Council's mission
and Charter objectives and is responsible for overall direction
and management of the Council, ensuring that the Council takes
an effective role in the governance of BBSRC. The overall responsibility
of the Chair is to ensure the effective and efficient performance
of BBSRC to deliver its strategy, mission and commitments.
KEY RESPONSIBILITIES
· Work
with BIS, the Chief Executive and the Council members in the development
of the Council's strategic direction and policies to deliver the
BBSRC's mission, within the overall framework of government policy;
· Effectively
chair Council meetings, typically four times a year, in a way
that facilitates the corporate pursuit of Council objectives and
gives due consideration to the interests of all stakeholders of
Council business;
· Work
to improve the links between the BBSRC, the research community
it supports, national and international research funding and policy
agencies, including learned and professional institutions, and
with Government and Parliament;
· Build
vital relationships with various partners aimed at realising the
potential of BBSRC research.
· Engage
senior users such as those in businesses to promote increased
engagement with BBSRC and thereby the relevance and economic impact
of BBSRC's research;
· Chair
the Appointments Panel which recommends to the Secretary of State
shortlists for appointments as Members of the Council. Assessing
the performance of the Chief Executive and Council Members;
· Chair
the Remuneration Committee, which determines Director-level pay
policy and contracts, and corporate bonuses, as well as periodic
attendance at relevant groups and sub-committees when required;
and
· Work
with BIS and the other Research Council and TSB Chairs and Chief
Executives on cross-Council research and other wider research
and innovation policy issues including industrial strategy.
PERSON SPECIFICATION
We are seeking an outstanding individual to become
Chair of the BBSRC. Applications are sought from candidates who
are able to command the confidence of the relevant academic and
related communities and who can guide the development of BBSRC's
economic as well as research and policy impacts. Ideally candidates
will have a strong interest in biotechnology and the biological
sciences.
ESSENTIAL SKILLS
The successful candidate will be able to demonstrate
the ability to:
· Chair
the Board of a substantial organisation and provide strategic
direction;
· Exercise
judgement across a broad spectrum of policy and high-level management
issues;
· Deal
with complex and difficult discussions with diplomacy and resolve;
· Engage
with a wide range of stakeholders at senior level, including Ministers
and senior officials within Government;
· Facilitate
and lead discussion of policy and other strategic matters drawing
in the skills, knowledge and expertise of all members of Council
and engaging with the Executive and other stakeholders to promote
effective decision making.
· A good
understanding of governance and other governing body management
issues such as an understanding of compliance and probity as these
relate to a publically-funded organisation.
· First
rate communication and interpersonal skills coupled with a strong
intellect and negotiation and influencing capability across a
range of stakeholders
· A commitment
to promote and embed diversity and an inclusive culture appropriate
for a public body.
DESIRABLE SKILLS
Some of the following attributes would be desirable:
· Understanding
of research-led organisations and the UK research base across
Government, research institutions and have credibility with academia
and industrial research sectors;
· Experience
of working for/with industry;
· Experience
of dealing with diverse interest groups;
· Understanding
of the biotechnology and the biological sciences research community.
CONFLICTS OF INTEREST
Potential candidates should be aware that the Council
must avoid conflicts of interest in its work, and therefore individuals
with significant responsibilities in bodies which bid for funding
from BBSRC, or which provide funding in significant areas in which
BBSRC is active, are not eligible.
Applicants are asked to declare any potential conflicts
on the Candidate Summary Form and to note that all members of
Council are required to declare any private, professional or commercial
interests that might conflict with the interests of the Council,
or which might be perceived by others as creating a conflict of
interest. These declarations are published on the BBSRC website.
TERMS OF APPOINTMENT
· This
is a part-time and non-executive appointment, for which an honorarium
is paid. The rate at appointment will be £16,430 per annum.
Expenses will be reimbursed;
· The
appointment is expected to be from 1 July 2015 for four years;
· There
is a degree of flexibility in the role, but typically in the order
of 24 days a year is expected. The Council formally meets four
times a year and there is also an annual away day.
Annex C - CV of the candidate
PROFESSOR SIR GORDON DUFF - CV
PRESENT POSTS
Principal, St Hilda's College, University of Oxford,
from August 2014
Chair, Strategic Partners Board, Imperial College
Academic Health Sciences Centre (AHSC)
Chair, Trinity Health Ireland, the AHSC of Trinity
College, Dublin
Chair, MRC-NIHR National Phenome Centre, Imperial
College London
EDUCATION
University of Oxford St Peter's College 1966-70
University of London MRC Student, Dept of Medicine,
St Thomas's Med School 1970-72
University of Oxford Clinical Student, (St Thomas's
Hospital, London) 1972-75
Univ London, NHS and RAF Post-graduate medical training
posts 1975-80
Yale University, USA Post-doctoral research training
1980-84
PREVIOUS POSTS
House Officer in Medicine (General, Cardiac, Haematology)
St Thomas's Hospital, London 07/75 -01/76
House Officer in Surgery (A&E, Orthopaedics)
Stracathro Hospital, Brechin, Scotland. 02/76 -08/76
SHO in Medicine, (Cardiology, Respiratory Medicine,
ITU, CCU) RAF Medical Unit Midhurst, Sussex 08/76 -08/77
SHO in Clinical Pharmacology, Hammersmith Hospital,
London 08/77 -02/78
Registrar in Medicine, St Thomas's Hospital, London
03/78 -02/79
Registrar in Medicine (1:2 rota) Royal Cornwall Hospital,
Treliske, Truro 02/79 -10/80
Research Fellow (NIH-funded), Infectious Diseases
and Immunology, Yale Medical School, USA 10/80 -12/83
Associate Investigator, Howard Hughes Institute of
Cellular and Molecular Immunology, Yale 11/81 -02/84
Clinical Lecturer in Rheumatology, University of
Edinburgh, Honorary Senior Registrar 02/84 -12/86
Clinical Senior Lecturer, Department of Medicine,
University of Edinburgh, Honorary Consultant 12/86 -12/90
Research Dean, Sheffield School of Medicine and Biomedical
Sciences 08/98 -08/02
Director of Research, Faculty of Medicine, Univ of
Sheffield, (Schools of Medicine &
Biomedical Sciences; Dentistry; Nursing & Midwifery;
Health and Related Research 08/00 -08/02
Director, Division of Molecular & Genetic Medicine,
University of Sheffield 08/97 -08/00
Director, Division of Genomic Medicine, University
of Sheffield 08/00 -09/05
Florey Professor of Molecular Medicine, University
of Sheffield (Honorary Consultant STHNHS Trust) 12/90 -12/12
Chair, Medicines and Healthcare products Regulatory
Agency (MHRA, UK National Regulator), London 01/13 -12/14
DEGREES / DIPLOMAS / HONS
University of Oxford BA - Animal Physiology 1969
University of Oxford MA - Physiology 1975
University of Oxford BM BCh - Medicine & Surgery
1975
Royal College of Physicians MRCP (UK) 1978
University of London PhD - Thermoregulatory Neuropharmacology
1980
Fellow, Royal College of Physicians FRCP (Edinburgh)
1989
Fellow, Royal College of Physicians FRCP (London)
1999
Fellow, Academy of Medical Sciences FMedSci (London)
1999
Fellow, Royal Society of Edinburgh FRSE 2008
University of Edinburgh Honorary MD 2008
Faculty of Pharmaceutical Medicine Honorary Fellow
(FFPM) 2008
British Pharmacological Society Honorary Fellow (FBPharmS)
2012
HONOURS / NAMED LECTURES / ETC
Open Scholarship in Medicine, St Peter's College,
University of Oxford 1966
MRC Training Scholarship, Department of Medicine,
St Thomas's Medical School 1970
Sir Hiram Maxim Award for Research in Immunology
(jointly with S K Durum, NIH, USA) 1987
Honiman-Gillespie Lecturer, University of Edinburgh
1991
Royal Society of Medicine Visiting Professorship
to USA (Yale, NIH, Pfizer Research) 1995
Harry Boström Lecturer and Medal of the Swedish
Society of Medicine (Cytokine Medicine) 1996
Medical Faculty Lecturer, University of Geneva 2001
Honorary Fellow, St Peter's College, Oxford 2006
Knighthood (for Services to the Public Health) 2007
Honorary Member, Association of Physicians of Great
Britain and Ireland 2007
Henry Fuller Lecturer, St George's University of
London 2010
Croonian Lecturer, Royal College of Physicians of
London 2010
Bourne Lecturer, St George's University, Grenada
2013
Science Council 100 top 'working scientists' in UK
2014
American Academy of Periodontology, Clinical Research
Award 2014
SUMMARY OF SCIENTIFIC ADVISORY/LEADERSHIP ACTIVITIES
UK National Government
Cabinet Office/DH Chairman of MHRA, UK national medicines
regulator 2013-2014
UK Clinical Research Consortium Member representing
MHRA 2013-2014
Department of Health (Secretary of State) Chairman,
UK Commission on Human Medicines (CHM) 2005-2013
Department of Health (Secretary of State) Chairman,
National Emergency Medicines Quality Panel 2010-2013
Cross-Government (Secretary of State) Chairman, Scientific
Pandemic Influenza Advisory Comm 2008-2013
Cabinet Office Co-chair Scientific Advisory Group
Emergencies (SAGE) 2009-2010
Department of Health (Secretary of State) Review
of National Organ Donor Register (single author) 2010
Department of Health (Secretary of State) Chairman,
Expert Scientific Group Phase 1 Clinical Trials 2006
Department of Health (Secretary of State) Chairman,
Committee on Safety of Medicines (CSM) 2003-2005
Department of Health (Secretary of State) Member
of Committee on Safety of Medicines (CSM) 1995-2005
Department of Health Chairman, Biological Sub-Committee
(CSM) 1998-2003
Department of Health Chairman, vCJD & Blood Products
Expert Group (CSM) 1998
Department of Health Chairman, vCJD & Vaccines
Expert Group (CSM) 2000
Department of Health Chairman, Tissue Engineering
Expert Group (CSM) 2001-2005
Department of Health Co-chairman, CSM / GTAC Gene
Therapy Group 2003-2003
Department of Health Member, Biological Sub-Committee
(CSM) 1995-1998
Department of Health Member, Safety and Efficacy
Sub-committee (CSM) 1992-1995
Department of Health (Secretary of State) Chairman,
National Biological Standards Board (NBSB) 2002-2009
Department of Health Member, Advisory Group on Genetics
Research 2003-2007
Department of Health Chairman, Commissioning Group
for Gene Therapy 2004-2007
Department of Trade & Industry (OST) Chairman,
Foresight International Health Group 1998-1999
Department of Trade & Industry (OST) Health and
Life Sciences Foresight Panel 1997-1999
Department of Trade & Industry (OST) Foresight
Healthcare, Genomic Medicine Group 01999-2000
UK National Non-Government
Imperial Academic Health Science Centre
(Imperial College, Hammersmith, St Mary's,
Charing Cross, Queen Charlotte's and
Chelsea Hospitals, West London Eye hospital) Chairman,
Strategic Partners Board 2013-present
MRC-NIHR National Phenome Centre (ICL) Chairman of
the Board 2013-present
MRC Centre for Drug Safety Sciences (L'pool) Chairman,
International Scientific Advisory Board 2010-present
Manchester Academic Health Sciences Centre Independent
Governor 2009-11
Medical Research Council (MRC) Member of Advisory
Board 1997-02
E & PS Research Council (EPSRC) Health Metrology
Panel 2000
Prix Galien Adjudicating Panel 2004-present
Medical Solutions plc International Scientific Advisory
Board 1999-2003
Guide Dogs for the Blind Association Member of Scientific
Committee 1996-99
Wellcome Trust Clinical Interest Group 1994-97
Arthritis and Rheumatism Council Member of Research
Committee 1993-97
International
Trinity College, Dublin,
Academic Health Sciences Centre Chairman (Trinity
Health Ireland) 2010-present
Molecular Medicine Ireland Chairman, International
Scientific Advisory Board 2008-2009
Dublin Molecular Medicine Centre International Scientific
Advisory Board 2000-2007
International Cytokine Society (USA) President 1997-1998
International Cytokine Society (USA) Chairman of
Conference Committee 1995
International Cytokine Society (USA) Council Member
1992-present
DeutschesRheumaForschungZentrum (Berlin) International
Scientific Advisory Board 1996-1999
Interleukin Genetics Inc (Boston, USA) Chairman,
International Scientific Advisory Board 1997-present
European Medicines Evaluation Agency Expert Advisor
List (Biological Medicines) 2001-present
European Cytokine Society (Paris) Council Member
1997-2006
Elsevier, journal, 'CYTOKINE' Editor-in-Chief (Co-founder)
1988-2014
Journal of Human Genome Organisation Editorial Advisor
2006-present
Local
University of Sheffield Member of Council (governing
body) 2000-2004
University of Sheffield Director of Research, Faculty
of Medicine (4 Schools) 2000-2002
University of Sheffield Carlisle Committee; Strategy
for Medicine & Biosciences 1994-1905
University of Sheffield Member of Medical School
Council 1997-2008
University of Sheffield Convenor, RAE UoA 3 Group
(5 or 5*) 2000-2001
University of Sheffield Chairman, Faculty of Medicine
RAE review Group 2000-2001
TECHNOLOGY TRANSFER AND COMMERCIAL (ALL LICENSED
OUT BY UNIVERSITY OF SHEFFIELD)
32 patents issued
European Patent Office: 13 patents issued 2001-10
US Patent Office: 19 patents issued 1997-10
Patents and PCT applications 6 pending
Patents in biotechnology and genetic diagnostics,
licensed out by Sheffield University
Company Directorships and Trusteeships
Director of Fairfield Imaging (Division of Medical
Solutions plc) 1999-02
Chairman/Director of Molecular Healthworks Ltd. (Univ
of Sheffield start-up) 2000-01
Chairman/Director of Molecular Skincare Ltd. (Univ
of Sheffield start-up) 2001-03
Trustee, The Over-volunteering Prevention System
(TOPS, to prevent over-exposure to clinical trials) 2007-12
Patron, St Luke's Hospice, Sheffield 2011-
POSTGRADUATE RESEARCH STUDENTS
External examiner/assessor for national and international
PhD/DPhil/MD/DSc degrees 29
PhD students supervised 19
RESEARCH INCOME
Total personal and institutional funding where main
or lead applicant/author since 1986 ~£43.4million
INVITED LECTURES AND ORAL PRESENTATIONS
National and International since 1982 ~300
GOVERNMENT REPORTS
Risk Assessment of Transmissible Spongiform Encephalopathy
in Vaccines used in the United Kingdom. Department of Health 1998
Risk Assessment of Transmissible Spongiform Encephalopathy
in Medicines used in the United Kingdom. Department of Health
1999
Report to Secretary of State of the Expert Scientific
Group on Phase One Clinical Trials. Department of Health 2006
Review of the Organ Donor Register; Final Report
to Secretary of State Department of Health 2010
RESEARCH PUBLICATIONS
Current list and Citation indices
http://scholar.google.co.uk/citations?user=s8R73YMAAAAJ&hl=en
3 1 John Innes Centre (Norwich), Institute of Food
Research (Norwich), The Genome Analysis Centre (Norwich), the
Babraham Institute (Cambridge) and Rothamsted Research (Harpenden). Back
| 
